What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Psychiatry
- Attention deficit hyperactivity disorder
Jeffrey H. Newcorn mostly deals with Attention deficit hyperactivity disorder, Psychiatry, El Niño, Clinical trial and Methylphenidate.
His study in Attention deficit hyperactivity disorder is interdisciplinary in nature, drawing from both Placebo and Internal medicine, Stimulant, Comorbidity.
Jeffrey H. Newcorn has included themes like Randomized controlled trial, Pediatrics and Clinical psychology in his Psychiatry study.
His Clinical psychology course of study focuses on Mental health and Sluggish cognitive tempo.
His work deals with themes such as Analysis of variance, Multimodal treatment, Developmental psychology, Psychometrics and Dosing, which intersect with El Niño.
The concepts of his Clinical trial study are interwoven with issues in Social skills and Treatment and control groups.
His most cited work include:
- Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. (1483 citations)
- The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study (847 citations)
- Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. (804 citations)
What are the main themes of his work throughout his whole career to date?
Jeffrey H. Newcorn mainly investigates Psychiatry, Attention deficit hyperactivity disorder, Clinical psychology, Methylphenidate and Developmental psychology.
His Atomoxetine, Stimulant, Comorbidity, Substance abuse and Conduct disorder study are his primary interests in Psychiatry.
He combines subjects such as Clinical trial, El Niño, Pediatrics, Randomized controlled trial and Placebo with his study of Attention deficit hyperactivity disorder.
His work in El Niño addresses issues such as Fenfluramine, which are connected to fields such as Serotonergic.
His Clinical psychology study integrates concerns from other disciplines, such as Psychosocial, Young adult, Aggression, Mental health and Severity of illness.
His research integrates issues of Multimodal treatment and Cognition in his study of Developmental psychology.
He most often published in these fields:
- Psychiatry (53.26%)
- Attention deficit hyperactivity disorder (49.86%)
- Clinical psychology (27.48%)
What were the highlights of his more recent work (between 2015-2021)?
- Attention deficit hyperactivity disorder (49.86%)
- Psychiatry (53.26%)
- Clinical psychology (27.48%)
In recent papers he was focusing on the following fields of study:
Jeffrey H. Newcorn mainly focuses on Attention deficit hyperactivity disorder, Psychiatry, Clinical psychology, Methylphenidate and Placebo.
The Attention deficit hyperactivity disorder study combines topics in areas such as Guanfacine, Rating scale, Cognition, Pediatrics and Double blind.
His research in Psychiatry intersects with topics in Young adult, Medical prescription and PsycINFO.
His Clinical psychology research incorporates themes from Symptom improvement, Drug-naïve, Substance abuse and Comorbidity.
As part of one scientific family, Jeffrey H. Newcorn deals mainly with the area of Methylphenidate, narrowing it down to issues related to the Morning, and often Functional impairment.
The various areas that Jeffrey H. Newcorn examines in his Placebo study include Internal medicine, Clinical trial, Tolerability and Extended release.
Between 2015 and 2021, his most popular works were:
- Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results. (124 citations)
- Young adult outcomes in the follow‐up of the multimodal treatment study of attention‐deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression (117 citations)
- Practitioner Review: Emotional dysregulation in attention‐deficit/hyperactivity disorder – implications for clinical recognition and intervention (71 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Psychiatry
- Major depressive disorder
His primary areas of study are Attention deficit hyperactivity disorder, Psychiatry, Clinical psychology, Rating scale and Internal medicine.
Jeffrey H. Newcorn mostly deals with Methylphenidate in his studies of Attention deficit hyperactivity disorder.
While working in this field, he studies both Psychiatry and Suicide prevention.
His work carried out in the field of Clinical psychology brings together such families of science as Psychosocial, Mental health and Comorbidity.
His Internal medicine research includes themes of Placebo, Nocebo and Extended release.
His Randomized controlled trial research includes elements of Multimodal treatment and Stimulant.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
